{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:25:33Z","timestamp":1751822733810},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1006\/phrs.1999.0548","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T15:08:06Z","timestamp":1034003286000},"page":"509-516","source":"Crossref","is-referenced-by-count":3,"title":["INFLUENCE OF 3-PPP, A SIGMA RECEPTOR LIGAND, ON THE ANTICONVULSIVE ACTION OF CONVENTIONAL ANTIEPILEPTIC DRUGS"],"prefix":"10.1006","volume":"40","author":[{"given":"K.K.","family":"BOROWICZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"KLEINROK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"CZUCZWAR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/phrs.1999.0548_PHRS.RF1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1432-1033.1991.tb16226.x","article-title":"Sigma receptors","volume":"200","author":"Su","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF2","first-page":"517","article-title":"The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF3","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1073\/pnas.78.9.5881","article-title":"Phencyclidine (angeldust)\/sigma `opiate' receptor: visualization by tritium sensitive film","volume":"78","author":"Quirion","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF4","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/0024-3205(86)90572-2","article-title":"Endogenous ligands for sigma opioid receptors in the brain (`sigmaphin'): evidence from binding assays","volume":"38","author":"Su","year":"1986","journal-title":"Life Sci"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF5","first-page":"187","article-title":"Delineating biochemical and functional properties of sigma receptors: emerging concepts","volume":"7","author":"Su","year":"1993","journal-title":"Crit Rev Neurobiol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF6","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF7","first-page":"355","article-title":"Sigma receptors: biology and function","volume":"42","author":"Walker","year":"1990","journal-title":"Pharmacol Rev"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0024-3205(95)02248-1","article-title":"Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands\u2014possible implications for the treatment of psychotic disorders","volume":"58","author":"Debonnel","year":"1996","journal-title":"Life Sci"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1096\/fasebj.7.12.8375616","article-title":"Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells","volume":"7","author":"Paul","year":"1993","journal-title":"FASEB J"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(97)01248-X","article-title":"2(3H)-benzoxazolone and 2(3H) benzothiazolone derivatives: novel, potent and selective sigma 1 receptor ligands","volume":"335","author":"Ucar","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0091-3057(90)90141-4","volume":"36","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.38.6.961","article-title":"Evidence for a role of haloperidol-sensitive-sigma-`opiate' receptors in the motor effects of antipsychotic drugs","volume":"38","author":"Walker","year":"1988","journal-title":"Neurology"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(93)90684-A","article-title":"A comparison of (\u2212)-deoxybenzomorphans devoid of opiate activity with their dextrorotary phenolic counterparts suggest role of sigma2receptor in motor function","volume":"231","author":"Walker","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0028-3908(93)90057-A","article-title":"Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A","volume":"32","author":"Poncelet","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(93)90456-R","article-title":"Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands","volume":"231","author":"Patrick","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF16","first-page":"351","article-title":"Electrophysiological and binding sites on intact NCB-20 cells suggest presence of a low affinity sigma receptor","volume":"257","author":"Wu","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(94)91232-7","article-title":"Characterization of the currents induced by sigma ligands in NCB-20 neuroblastoma cells","volume":"637","author":"Morio","year":"1994","journal-title":"Brain Res"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF18","unstructured":"Soriani, O, Vaudry, H, Mei, Y, A, Roman, F, Cazin, L, Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein- dependent inhibition of potassium conductances, J Pharmacol Exp Ther, 286, 163, 71"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90607-J","article-title":"The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex","volume":"236","author":"Roth","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-2999(84)90013-X","article-title":"Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice","volume":"100","author":"Czuczwar","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(91)90582-B","article-title":"Influence of MK-801 on the anticonvulsant activity of antiepileptics","volume":"200","author":"Urba\u0144ska","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(93)90728-Z","article-title":"Competitive antagonists of NMDA receptor: CGP 37849 and CGP 39551 enhance the antielectroshock activity of valproate against electroconvulsions in mice","volume":"232","author":"Czechowska","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90613-M","article-title":"Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics","volume":"250","author":"Pietrasiewicz","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0028-3908(94)90166-X","article-title":"The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice","volume":"33","author":"Zarnowski","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01277958","article-title":"The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective activity of common antiepileptics against maximal electroshock-induced seizures in mice","volume":"97","author":"Zarnowski","year":"1994","journal-title":"J Neural Transm"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1528-1157.1996.tb00625.x","article-title":"Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock in mice","volume":"37","author":"Borowicz","year":"1996","journal-title":"Epilepsia"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF27","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/0024-3205(86)90640-5","article-title":"Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain","volume":"38","author":"Ferris","year":"1986","journal-title":"Life Sci"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s007020050082","article-title":"Rimcazole, a sigma receptor ligand, and the anticonvulsive action of conventional antiepileptic drugs","volume":"105","author":"Borowicz","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle methode simple pour explorer l'action'tranquilisante: le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp (Basel)"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF31","first-page":"99","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","article-title":"Sigma1 receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism","volume":"83","author":"Maurice","year":"1998","journal-title":"Neuroscience"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF33","first-page":"107","article-title":"Steroid binding at sigma receptors: CNS and immunological implications","volume":"153","author":"Su","year":"1990","journal-title":"Ciba Found Symp"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/(SICI)1097-4547(19961215)46:6<734::AID-JNR10>3.0.CO;2-U","article-title":"Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10047 binding to sigma 1 receptors in the mouse forebrain","volume":"46","author":"Maurice","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(92)90388-K","article-title":"Persistent supersensitivity of sigma receptor develops during repeated methamphetamine treatment","volume":"211","author":"Ujike","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00002826-198804000-00002","article-title":"The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy","volume":"11","author":"Deutsch","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0361-9230(92)90078-C","article-title":"Iontophoretic effects of sigma ligands on rubral neurons in the rat","volume":"29","author":"Matsumoto","year":"1992","journal-title":"Brain Res Bull"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0893-133X(89)90023-7","article-title":"Electrophysiological effects of selective sigma receptor agonists, antagonists and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons","volume":"2","author":"Steinfels","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0014-2999(95)00617-6","article-title":"Sigma (1) receptors in rat striatum regulate NMDA-stimulated (H-3) dopamine release via a presynaptic mechanism","volume":"294","author":"Gonzalezalvear","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(91)90747-J","article-title":"Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N -methyl- d -aspartate (NMDA) receptor complex- mediated events by sigma ligands","volume":"561","author":"Rao","year":"1991","journal-title":"Brain Res"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","article-title":"N -Methyl- d -a spartate-induced neuronal activation is selectively modulated by sigma receptors","volume":"179","author":"Monnet","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF42","first-page":"123","article-title":"In vivo electrophysiological evidence for a selective modulation of N - methyl- d -aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands","volume":"261","author":"Monnet","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1476-5381.1994.tb13134.x","article-title":"The effects of sigma ligands and of neuropeptide Y on N -methyl- d -aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin","volume":"112","author":"Monnet","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0306-3623(94)00191-O","article-title":"3-(3- Hydroxyphenyl)- N -(1-propyl)piperidine elicits convulsant effects in mice","volume":"26","author":"Pieretti","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF45","first-page":"473","article-title":"Effects of the selective sigma receptor ligand, 6-[-(4-hydroxypiperi- dinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocain e","volume":"266","author":"Witkin","year":"1993","journal-title":"J. Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF46","first-page":"154","article-title":"Inhibition of N -methyl- d -aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors","volume":"279","author":"Lynch","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(94)91398-6","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)83020-8","article-title":"SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice","volume":"328","author":"Maurice","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0278-5846(96)00160-1","article-title":"Neuroprotective and anti-amnestic potentials of sigma receptor ligands","volume":"21","author":"Maurice","year":"1997","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(95)00415-8","article-title":"Effects of sigma ligands on the extracellular concentratio n of dopamine in the striatum and prefrontal cortex of the rat","volume":"286","author":"Gudelsky","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF52","first-page":"513","article-title":"Brain dopamine and seizure susceptibility in mice","volume":"30","author":"Kleinrok","year":"1978","journal-title":"Pol J Pharmacol"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1980.tb04303.x","article-title":"Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice","volume":"21","author":"Kleinrok","year":"1980","journal-title":"Epilepsia"},{"key":"10.1006\/phrs.1999.0548_PHRS.RF54","first-page":"1219","article-title":"Neuropeptide Y potentiates the N -methyl- d -aspartate response in the CA3 dorsal hippocampus","volume":"263","author":"Monnet","year":"1992","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661899905480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661899905480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T22:15:47Z","timestamp":1576620947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661899905480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S1043661899905480"],"URL":"https:\/\/doi.org\/10.1006\/phrs.1999.0548","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}